Trials / Conditions / Extramedullary Disease in Multiple Myeloma
Extramedullary Disease in Multiple Myeloma
3 registered clinical trials studyying Extramedullary Disease in Multiple Myeloma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Mu NCT07382739 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients NCT06572605 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Recruiting | Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Pa NCT06627751 | Roswell Park Cancer Institute | Phase 2 |